A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia-Reference-Cited by-同舟云学术

A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia

Published:2019-03-26 Issue:3 Volume:14 Page:e0212837
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Arrieta Antonio C.,Sung Lillian,Bradley John S.,Zwaan C. Michel,Gates Davis,Waskin Hetty,Carmelitano Patricia,Groll Andreas H.,Lehrnbecher Thomas,Mangin Eric,Joshi Amita,Kartsonis Nicholas A.,Walsh Thomas J.,Paschke Amanda^ORCID

Funder

Merck

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference18 articles.

1. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors;JM Wiley;J Clin Oncol,1990

2. Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution;GP Rosen;J Pediatr Hematol Oncol,2005

3. Fungal infections in children with cancer: a prospective, multicenter surveillance study;E Castagnola;Pediatr Infect Dis J,2006

4. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years;L Hovi;Bone Marrow Transplant,2000

5. Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation;CC Dvorak;Bone Marrow Transplant,2005

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Invasive fungal disease and antifungal prophylaxis in children with acute leukaemia: a multicentre retrospective Australian cohort study;The Lancet Regional Health - Western Pacific;2024-11

2. Infectious complications in the paediatric immunocompromised host: a narrative review;Clinical Microbiology and Infection;2024-06

3. Posaconazole in paediatric malignancy and haematopoietic stem cell transplant: dosing to achieve therapeutic concentration;Journal of Antimicrobial Chemotherapy;2024-04-18

4. A population pharmacokinetic model for posaconazole intravenous solution and oral powder for suspension formulations in pediatric patients with neutropenia;Antimicrobial Agents and Chemotherapy;2024-04-03

5. Therapeutic drug monitoring of antifungal therapies: do we really need it and what are the best practices?;Expert Review of Clinical Pharmacology;2024-02-21